Get started
Author

Elena Giordani

Observed names: GIORDANI, Elena, Giordani, Elena
ORCID: 0000-0002-6445-4509
Observed ORCID: 0000-0002-6445-4509
OpenAlex ID: A5033210472
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
2023 · Elena Ricciardi, Elena Giordani, et al. · International Journal of Molecular Sciences · 43
PDF
A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery
2020 · Jessica Gasparello, Chiara Papi, et al. · Cancers · 42
PDF
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
2023 · Patrizio Giacomini, Fabio Valenti, et al. · Journal of Translational Medicine · 29
PDF
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
2020 · Matteo Allegretti, Giuliano Cottone, et al. · Journal of Experimental & Clinical Cancer Research · 29
PDF
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
2021 · Matteo Allegretti, Alessandra Fabi, et al. · Molecular Cancer · 21
PDF
A novel method for detecting genetic biomarkers in blood-based liquid biopsies using surface plasmon resonance imaging and magnetic beads shows promise in cancer diagnosis and monitoring
2025 · Noemi Bellassai, Roberta D'Agata, et al. · Talanta · 20
Surface plasmon resonance biosensor with anti-crossing modulation readout
2024 · Roger Hasler, Dario Cattozzo Mor, et al. · Sensors and Actuators B Chemical · 19
PDF
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients
2024 · Elena Giordani, Matteo Allegretti, et al. · Journal of Experimental & Clinical Cancer Research · 14
PDF
Bioassay engineering: a combined label-free and fluorescence approach to optimize HER2 detection in complex biological media
2020 · Alberto Sinibaldi, Andrea Doricchi, et al. · Analytical and Bioanalytical Chemistry · 14
Direct competitive assay for HER2 detection in human plasma using Bloch surface wave-based biosensors
2023 · Tommaso Pileri, Alberto Sinibaldi, et al. · Analytical Biochemistry · 9
PDF
Direct Competitive Assay for ERBB2 Detection in Breast Cancer Cell Lysates Using 1-D Photonic Crystals-Based Biochips
2023 · Alberto Sinibaldi, Matteo Allegretti, et al. · IEEE Sensors Letters · 9
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers
2023 · Giulio Fracasso, Elisabetta Falvo, et al. · Heliyon · 5
PDF
Facile Fabrication of Large‐Area Biofunctionalized Metallic Nanostructures for High Performance Affinity Plasmonic Biosensors
2025 · Dario Cattozzo Mor, Adam Benjamin Plšek, et al. · Advanced Materials Technologies · 2
PDF
Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
2023 · Matteo Allegretti, Vittoria Barberi, et al. · Frontiers in Oncology · 2
PDF
Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols
2019 · Jessica Gasparello, Matteo Allegretti, et al. · Journal of Cancer Metastasis and Treatment · 2
PDF
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer
2026 · Alessandra Fabi, Elena Giordani, et al. · Journal of Experimental & Clinical Cancer Research · 1
Abstract OT1-22-01: Liquid biopsy and Ado-trastuzumab emtansine (T-DM1): drug-resistance traits in the blood of HER2-positive metastatic breast cancer patients
2023 · Alessandra Fabi, Matteo Allegretti, et al. · Cancer Research · 1
Dynamic circulating tumor DNA (ctDNA) in monitoring trastuzumab deruxtecan (TDXd) activity for patients (pts) with advanced breast cancer: Preliminary results of a feasibility study.
2022 · Elena Giordani, Antonella Palazzo, et al. · Journal of Clinical Oncology · 1
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer
2026 · Fabi, Alessandra, Giordani, Elena, et al. · Figshare
End9: an early-passage cell line defective in master HLA-I transcriptional coordinators
2022 · Elisa Tremante, Aline Martayan, et al. · Molecular Immunology
Multiplexed bio-assay for a reliable detection of HER2 in human plasma using a combined label-free/fluorescence biosensing platform
2022 · Tommaso Pileri, Alberto Sinibaldi, et al. · Frontiers in Biological Detection: From Nanosensors to Systems
Optical multiplexed bioassays on photonic crystals for breast cancer biomarker detection
2021 · Tommaso Pileri, Alberto Sinibaldi, et al. · EPJ Web of Conferences
PDF
Label-free and fluorescence photonic crystal biochips for early cancer biomarker detection
2019 · Alberto Sinibaldi, Norbert Danz, et al. · Frontiers in Biological Detection: From Nanosensors to Systems
Works count: 38
Citation count: 263
H-index: 9
I10-index: 9
Year
Topic
Type